These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 19881315

  • 1. Demonstration of basic proteins that bind retinoic acid in the human myeloid leukemia cell line HL60.
    Takahashi N, Ohba T.
    Biol Pharm Bull; 2009 Nov; 32(11):1943-6. PubMed ID: 19881315
    [Abstract] [Full Text] [Related]

  • 2. Proteins in human myeloid leukemia cell line HL60 reacting with retinoic acid monoclonal antibodies.
    Kubo Y, Ohba T, Takahashi N.
    J Biochem; 2008 Sep; 144(3):349-55. PubMed ID: 18511450
    [Abstract] [Full Text] [Related]

  • 3. Retinoylation (covalent modification by retinoic acid) of Rho-GDIβ in the human myeloid leukemia cell line HL60 and its functional significance.
    Takahashi N, Ohba T, Imai M, Hasegawa S, Takahashi K, Yamasaki M, Kameoka Y.
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2011-2019. PubMed ID: 27720952
    [Abstract] [Full Text] [Related]

  • 4. Retinoylation of proteins in leukemia, embryonal carcinoma, and normal kidney cell lines: differences associated with differential responses to retinoic acid.
    Takahashi N, Breitman TR.
    Arch Biochem Biophys; 1991 Feb 15; 285(1):105-10. PubMed ID: 1990968
    [Abstract] [Full Text] [Related]

  • 5. Retinoylation of vimentin in the human myeloid leukemia cell line HL60.
    Takahashi N, Breitman TR.
    J Biol Chem; 1994 Feb 25; 269(8):5913-7. PubMed ID: 7509793
    [Abstract] [Full Text] [Related]

  • 6. Retinoylation of the cAMP-binding regulatory subunits of type I and type II cAMP-dependent protein kinases in HL60 cells.
    Takahashi N, Liapi C, Anderson WB, Breitman TR.
    Arch Biochem Biophys; 1991 Nov 01; 290(2):293-302. PubMed ID: 1656875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protein kinase A activation by retinoic acid in the nuclei of HL60 cells.
    Sakai A, Imai M, Takahashi K, Hasegawa S, Yamasaki M, Ohba T, Takahashi N.
    Biochim Biophys Acta Gen Subj; 2017 Feb 01; 1861(2):276-285. PubMed ID: 27913186
    [Abstract] [Full Text] [Related]

  • 10. Cyclic AMP-dependent and -independent protein kinases and protein phosphorylation in human promyelocytic leukemia (HL60) cells induced to differentiate by retinoic acid.
    Fontana JA, Emler C, Ku K, McClung JK, Butcher FR, Durham JP.
    J Cell Physiol; 1984 Jul 01; 120(1):49-60. PubMed ID: 6588051
    [Abstract] [Full Text] [Related]

  • 11. Unassembled (soluble) vimentin in human myeloid leukemia cell line HL60.
    Takahashi N, Breitman TR.
    Eur J Haematol; 1994 Aug 01; 53(2):78-84. PubMed ID: 7522191
    [Abstract] [Full Text] [Related]

  • 12. Retinoic acid acylation (retinoylation) of a nuclear protein in the human acute myeloid leukemia cell line HL60.
    Takahashi N, Breitman TR.
    J Biol Chem; 1989 Mar 25; 264(9):5159-63. PubMed ID: 2925686
    [Abstract] [Full Text] [Related]

  • 13. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR, He RY.
    Cancer Res; 1990 Oct 01; 50(19):6268-73. PubMed ID: 2400989
    [Abstract] [Full Text] [Related]

  • 14. Induction of differentiation and apoptosis in human promyelocytic leukemia HL60 cell line by a new type of steroids.
    Takahashi N, Fukui T, Iwahori A, Kubo Y, Hosoe T, Kawai K.
    Exp Cell Res; 1998 Dec 15; 245(2):313-20. PubMed ID: 9851872
    [Abstract] [Full Text] [Related]

  • 15. Cyclic AMP-dependent protein kinase isoenzymes in human myeloid leukemia (HL60) and breast tumor (MCF-7) cells.
    Taimi M, Breitman TR, Takahashi N.
    Arch Biochem Biophys; 2001 Aug 01; 392(1):137-44. PubMed ID: 11469804
    [Abstract] [Full Text] [Related]

  • 16. Retinoic acid treated HL60 cells express CEACAM1 (CD66a) and phagocytose Neisseria gonorrhoeae.
    Pantelic M, Chen I, Parker J, Zhang P, Grunert F, Chen T.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):261-6. PubMed ID: 15364113
    [Abstract] [Full Text] [Related]

  • 17. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, Danilenko M, Kornblau S, Berestein GL.
    Mol Cancer Res; 2007 Jan 01; 5(1):95-108. PubMed ID: 17259349
    [Abstract] [Full Text] [Related]

  • 18. Gs alpha availability to cholera toxin-catalysed ADP-ribosylation is decreased in membranes of retinoic acid-treated leukemic cell lines HL-60 and THP-1. A posttranslational effect.
    de Cremoux P, Zimber A, Calvo F, Lanotte M, Mercken L, Abita JP.
    Biochem Pharmacol; 1991 Nov 06; 42(11):2141-6. PubMed ID: 1659820
    [Abstract] [Full Text] [Related]

  • 19. Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis.
    Bunce CM, Wallington LA, Harrison P, Williams GR, Brown G.
    Leukemia; 1995 Mar 06; 9(3):410-8. PubMed ID: 7885039
    [Abstract] [Full Text] [Related]

  • 20. Accumulation of hypoxia-inducible factor-1 alpha protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid.
    Zhang J, Song LP, Huang Y, Zhao Q, Zhao KW, Chen GQ.
    Haematologica; 2008 Oct 06; 93(10):1480-7. PubMed ID: 18728026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.